Compounded
Semaglutide
Any prescribed dose up to 2.5 mg/week
Prescription & clinician review included
Shipping included
$948 due today
Back to All Reviews
Investigation Report
Vios Compounding Tirzepatide Review
Vios, Vios Compounding Pharmacy, vioscompounding.com
Also spelled as Vios, Vios Compounding Pharmacy, vioscompounding.com — Same brand, same great service!
Our investigation of Compounded Tirzepatide from Vios Compounding
Caution Advised
Multiple red flags identified
5.8/10
Caution AdvisedRank#136 of 227
Visit Vios CompoundingPrescription treatment requires clinician review
Caution Advised
Not published
100+
Hours Researched
5
Verified Pros
8
Issues Found
5.8
Final Score
These are Med Consumer Watch products, not products from Vios Compounding, the brand being reviewed on this page.
Med Consumer Watch GLP-1 plans
GLP-1 weight loss.
A brand on your side.
Med Consumer Watch exists to help consumers make informed choices. Our brand brings that mission to GLP-1 care: clear plan prices, clinician review and support included, so you can compare your options and get started with confidence.
Why choose Med Consumer Watch?
Know your full price
Medication, clinician review and shipping are included. See your total before you buy.
Same price at every included dose
Your plan price stays the same across its included prescribed doses. Choose 1, 3, 6 or 12 months.
Support beyond your prescription
Ongoing doctor messaging, health coaching and patient community access are included with your plan.
Choose your medication and the plan length that works for you.
Buy semaglutide
Compounded
Tirzepatide
Any prescribed dose up to 15 mg/week
Prescription & clinician review included
Shipping included
$1,548 due today
Treatment requires a prescription and clinician approval. If treatment is declined, your payment is refunded. Compounded medications are not FDA-approved.
Investigation Overview
Vios is a compounding pharmacy reviewed here for the same reason as Empower and Strive — it may be the entity behind the medication a telehealth provider ships you. Our research (August 8, 2026) found the least disclosed of the three.
The Missing Disclosure
The single most important fact about any compounding pharmacy is which regulatory pathway it operates under:- 503A — traditional compounding for an individual patient against a specific prescription, regulated by state boards of pharmacy
- 503B — an FDA-registered outsourcing facility subject to federal cGMP requirements and routine FDA inspection
What It Does Say
The site references a "Quality & Compliance Overview" and states it follows "a strict system of checks and balances from formulation to final packaging to ensure safety and accuracy." That is a quality claim without a verifiable standard attached. Unlike Strive's published third-party sterility, potency and endotoxin testing, or its 90-day beyond-use dating, there is no external benchmark here that a patient or prescriber could check.Products and Distribution
- GLP-1 injections
- GLP-1 oral strips — an unusual formulation
What We Could Not Establish
Physical location and headquarters are not stated in the material we reviewed, nor are pricing, refund terms, or any accreditation.Our Investigation Summary
Our research (August 8, 2026) found Vios Compounding to be the least-disclosed of the three compounding pharmacies we have examined. It compounds GLP-1 injections and GLP-1 oral strips, operates a dual model serving patients directly as well as through provider partnerships, and advertises fast secure shipping to 49 states. What it does not disclose is the thing that matters most: whether it operates as a 503A compounding pharmacy or a 503B outsourcing facility — materially different levels of regulatory oversight, with 503B facilities being FDA-registered and subject to federal cGMP requirements and inspection. No accreditations are listed either. By contrast Empower states it is both 503A and 503B, and Strive discloses 503A status alongside PCAB, NABP and LegitScript accreditation plus published third-party sterility, potency and endotoxin testing and 90-day beyond-use dating. Vios offers a quality claim — "a strict system of checks and balances from formulation to final packaging" — without a verifiable standard attached. Physical location, pricing and refund terms were also not established. A pharmacy shipping compounded injectables directly to consumers in 49 states should say more than this.
How Vios Compounding Works
1
Vios operates a dual model — it serves patients directly and also partners with healthcare providers
2
Its GLP-1 products are compounded injections and GLP-1 oral strips
3
Medication is shipped to patients across 49 states
4
If a telehealth provider routes your prescription here, ask which regulatory pathway Vios operates under — 503A or 503B
5
Ask what accreditations it holds, since none are published
6
Ask for the beyond-use date and any third-party testing results for your batch
What We Found
What's Good
- Ships to 49 states with fast, secure delivery to the door
- Operates a dual model serving both patients directly and healthcare providers
- Offers GLP-1 oral strips alongside injections — an unusual formulation for people who prefer not to inject
- States it follows a system of checks and balances from formulation through final packaging
- References a Quality & Compliance Overview
Watch Out For
- Does not disclose whether it is a 503A pharmacy or a 503B outsourcing facility — the single most important fact about a compounder
- No accreditations listed — no PCAB, NABP, LegitScript or equivalent, where competitors publish theirs
- No published third-party sterility, potency or endotoxin testing, unlike other compounders we have reviewed
- No beyond-use dating published
- Physical location and headquarters not stated
- No pricing or refund terms published
- Ships compounded injectables direct to consumers in 49 states without evidencing its regulatory standing
- Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or manufacturing quality
Pricing Breakdown
Starting Price
Not published
Medication Cost
Not published. Products are compounded GLP-1 injections and GLP-1 oral strips
Subscription Fees
Not published
Hidden Fees
Not established. No pricing, refund terms or accreditations were disclosed in the material we reviewed
Safety & Medical Oversight
Vios Compounding does not disclose whether it operates as a 503A compounding pharmacy or a 503B outsourcing facility. That distinction determines the level of regulatory oversight applied to the sterile injectables it produces: 503A pharmacies are regulated primarily by state boards of pharmacy, while 503B outsourcing facilities are FDA-registered and subject to federal current Good Manufacturing Practice requirements and routine FDA inspection. No accreditations — PCAB, NABP, LegitScript or otherwise — are listed. The company states it follows "a strict system of checks and balances from formulation to final packaging to ensure safety and accuracy," but attaches no external standard, testing regime or beyond-use dating to that claim, unlike other compounders we have reviewed which publish third-party sterility, potency and endotoxin testing. Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or manufacturing quality before reaching patients. If your medication comes from here, ask directly: which pathway, which accreditations, what beyond-use date, and what testing was performed on your batch. GLP-1 receptor agonists are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Customer Support
Vios serves both patients directly and healthcare providers, advertising fast secure shipping to 49 states with delivery to the door. Beyond that, support structures, refund handling, pricing and physical location were not established in the material we reviewed. The direct-to-patient channel means some customers will have a relationship with the pharmacy itself rather than only through a prescriber — which makes the absence of published regulatory and accreditation information more consequential, not less.
Key Features
Compounded GLP-1 Injections
GLP-1 Oral Strips
Ships to 49 States
Direct-to-Patient and Provider Channels
Quality & Compliance Overview Referenced
503A/503B Status Not Disclosed
No Accreditations Published
Best For
Nobody should choose a compounder blind. If a provider routes your prescription here, ask which pathway it operates under and what accreditations it holds before accepting the medication
Customer Reviews & Complaints
Vios is a compounding pharmacy rather than a consumer telehealth brand, so the meaningful record is regulatory and accreditation. We looked for both as of August 8, 2026 and found neither published.
What we verified directly from the company's own pages: compounded GLP-1 injections and GLP-1 oral strips, a dual model serving patients directly and through provider partnerships, shipping to 49 states, and a general quality statement about checks and balances from formulation to final packaging.
What we could not establish: whether it operates as a 503A pharmacy or a 503B outsourcing facility, what accreditations it holds, what testing it performs, what beyond-use dating it assigns, where it is physically located, what it charges, or what its refund terms are.
Why that list matters. We have reviewed two other compounders for this site. Empower discloses that it is both a 503A pharmacy and a 503B outsourcing facility — which is how we were able to find and report its FDA warning letters. Strive discloses 503A status, PCAB, NABP and LegitScript accreditation, third-party sterility, potency and endotoxin testing, and 90-day beyond-use dating — which is how we were able to assess it favourably. Disclosure is what makes evaluation possible in either direction. Its absence is not evidence of a problem, but it removes every means of checking.
Is Vios Compounding Legit?
"Is Vios Compounding legitimate?" Our assessment as of August 8, 2026.
What we can say: Vios operates a functioning compounding pharmacy business shipping to 49 states through both direct-to-patient and provider channels. We found no evidence of wrongdoing, no enforcement actions and no complaint pattern.
What we cannot say is almost everything else. We could not establish its regulatory pathway, its accreditations, its testing standards, its beyond-use dating, or its physical location — and none of those are obscure technical details. They are the standard disclosures by which any compounding pharmacy is evaluated, and two of the three compounders we have reviewed publish them.
The direct-to-consumer channel raises the stakes. A pharmacy compounding sterile injectables and shipping them to patients in 49 states is operating at meaningful scale. At that scale, stating whether you are FDA-registered under 503B or state-regulated under 503A is not an optional marketing detail.
Red Flags Check:
- ✓ Functioning operation with a stated quality process
- ✓ Broad shipping reach across 49 states
- ✓ Offers an unusual oral strip formulation
- ✓ No enforcement actions or complaint pattern found
- ⚠ 503A versus 503B status not disclosed
- ⚠ No accreditations published
- ⚠ No third-party testing or beyond-use dating published
- ⚠ Physical location not stated
- ⚠ No pricing or refund terms published
The Bottom Line: We are not alleging anything against Vios — we are reporting that we could not verify the things that normally allow a compounder to be assessed. If a telehealth provider tells you your medication comes from here, ask four questions before accepting it: are you 503A or 503B, what accreditations do you hold, what is the beyond-use date on my vial, and what testing was performed on my batch. A pharmacy with good answers will give them. As always, discuss any concern about a medication you are taking with your prescribing clinician.
Our Verdict: Caution Advised
Vios Compounding has a 5.8/10 site score. We've identified some concerns that potential customers should be aware of. We recommend reviewing our top picks before proceeding.
Visit Vios CompoundingVios Compounding
Caution Advised
5.8/10
Not published
Prescription treatment requires clinician review
Investigation Summary
Overall Rank#136 of 227
Rating5.8/10
StatusCaution Advised
PricingNot published
Share Your Experience
Help others by sharing your experience with Vios Compounding
Want to compare options?
View All 227 ProvidersUser Reviews
Rating Summary
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
227 Providers Reviewed
Explore Other Reviews
Compare with other GLP-1 weight loss providers we've investigated
Our Top Picks
Promotional placement: CoreAge Rx is featured #1 and SuperHealthy Rx #2. Placements and site scores are not independent clinical ratings or patient review averages. We may earn compensation from referral links. How our rankings work.
#1 RecommendedExcellent
#2 RecommendedExcellent
#3 RecommendedExcellent
Likeness Rx
9.5
Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
More Provider Reviews
CoreAge Rx
9.9
SuperHealthy Rx
9.7
Likeness Rx
9.5
Mochi Health
8.8
Remedy Meds
8.3
Caution Advised
Ready to Get Started with Vios Compounding?
Review our findings above and make an informed decision about Vios Compounding.
Enter to Win a $1,788 CoreAge Rx Gift Card
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.